Sunday, August 8, 2010

BIOPHARMACEUTICS AND PHARMACOKINETICS ,PHARMCY SUBJECTS,THEIR TOPICS AND TEXT BOOKS AND REFERANCE BOOKS

BIOPHARMACEUTICS AND PHARMACOKINETICS ,PHARMCY SUBJECTS,THEIR TOPICS AND TEXT BOOKS AND REFERANCE BOOKS
GET IT AS A PDF AS YOUR PERSONAL COPY
BIOPHARMACEUTICS AND PHARMACOKINETICS
1. Biopharmaceutics
1. Introduction to Biopharmaceutics
a. Absorption of drugs from gastrointestinal tract.
b. Drug Distribution.
c. Drug Elimination.
2. Pharmacokinetics
2. Introduction to Pharmacokinetics.
a. Mathematical model
b. Drug levels in blood.
c. Pharmacokinetic model
d. Compartment models
e. Pharmacokinetic study.
3. One compartment open model.
a. Intravenous Injection (Bolus)
b. Intravenous infusion.
4. Multicompartment models.
a. Two compartment open model.
b. IV bolus, IV infusion and oral administration
5. Multiple – Dosage Regimens.
a. Repititive Intravenous injections – One Compartment Open Model
b. Repititive Extravascular dosing – One Compartment Open model
c. Multiple Dose Regimen – Two Compartment Open Model
6. Nonlinear Pharmacokinetics.
a. Introduction
b. Factors causing Non-linearity.
c. Michaelis-menton method of estimating parameters.
7. Noncompartmental Pharmacokinetics.
a. Statistical Moment Theory.
b. MRT for various compartment models.
c. Physiological Pharmacokinetic model.
8. Bioavailability and Bioequivalence.
a. Introduction.
b. Bioavailability study protocol.
c. Methods of Assessment of Bioavailability

BIOPHARMACEUTICS AND PHARMACOKINETICS

1. Improvement of dissolution characteristics of slightly soluble drugs by some methods.
2. Comparison of dissolution studies of two different marketed products of same drug.
3. Influence of polymorphism on solubility and dissolution.
4. Protein binding studies of a highly protein bound drug and poorly protein bound drug.
5. Extent of plasma-protein binding studies on the same drug (i.e. highly and poorly
protein bound drug) at different concentrations in respect of constant time.
6. Bioavailability studies of some commonly used drugs on animal/human model.
7. Calculation of Ka, Ke, t1/2, Cmax, AUC, AUMC, MRT etc. from blood profile data.
8. Calculation of bioavailability from urinary excretion data for two drugs.
9. Calculation of AUC and bioequivalence from the given data for two drugs.
10. In vitro absorption studies.
11. Bioequivalency studies on the different drugs marketed.(eg) Tetracycline, Sulphamethoxzole,
Trimethoprim, Aspirin etc., on animals and human volunteers.
12. Absorption studies in animal inverted intestine using various drugs.
13. Effect on contact time on the plasma protein binding of drugs.
14. Studying metabolic pathways for different drugs based on elimination kinetics data.
15. Calculation of elimination half-life for different drugs by using urinary elimination data and blood level data.
16. Determination of renal clearance.
References:
a. Biopharmaceutics and Clinical Pharmacokinetics by, Milo Gibaldi
b. Remington’s Pharmaceutical Sciences, By Mack Publishing Company, Pennsylvnia.
c. Pharmacokinetics: By Milo Glbaldi Donald, R. Mercel Dekker Inc.
d. Hand Book of Clinical Pharmacokinetics, By Milo Gibaldi and Laurie Prescott by ADIS Health Science Press.
e. Biopharmaceutics and Pharmacokinetics; By Robert F Notari
f. Biopharmaceutics; By Swarbrick
g. Bio pharmaceutics and Pharmacokinetics-A Treatise, By D. M. Brahmankar and Sunil
B.Jaiswal, Vallabh Prakashan Pitampura, Delhi
h. Cilincal Pharmacokinetics, Concepts and Applications: By Malcolm Rowland and
Thomas, N. Tozen, Lea and Febrger, Philadelphia, 1995.
i. Dissolution, Bioavailability and Bioequivalence, By Abdou H.M, Mack, Publishing
Company, Pennsylvania 1989.
j. Biopharmaceutics and Clinical Pharmacokinetics-An introduction 4th edition Revised
and expanded by Rebort F Notari Marcel Dekker Inn, New York and Basel, 1987.
k. Encyclopedia of Pharmaceutical Technology, Vol 13, James Swarbrick, James, C.
Roylan, Marcel Dekker Inc, New York 1996.


No comments: